| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in investing activities | -118,179 | -55,424 |
| Proceeds from issuance of class a ordinary shares under incentive award plans and employee share purchase plan | 32,177 | 15,925 |
| Payments in connection with ordinary shares tendered for employee tax obligations | 6,812 | 2,459 |
| Net cash provided by financing activities | 25,365 | 13,466 |
| Net decrease in cash and cash equivalents | -8,723 | 8,456 |
| Cash and cash equivalents at beginning of period | 183,581 | - |
| Cash and cash equivalents at end of period | 174,858 | - |
Kiniksa Pharmaceuticals International, plc (KNSA)
Kiniksa Pharmaceuticals International, plc (KNSA)